A cardiometabolic member relationship lasts for years and succeeds or fails based on onboarding, adherence, and re-engagement. We create the lifecycle marketing program that moves members from enrolled to engaged to retained – built for a chronic-disease journey rather than a consumer purchase, and measured against the outcomes that drive payer renewals.
The Challenge
You invest heavily in acquisition while letting members leak out the back
Cardiometabolic companies spend heavily to acquire a member through expensive clinical and paid channels, then hand them off to a thin lifecycle program that cannot keep them engaged. When 30 to 50 percent of enrolled members go dark before they activate, acquisition efficiency is irrelevant – you are refilling a leaking bucket. Lifecycle is the highest-ROI marketing surface in the business, and it is chronically under-resourced relative to paid.
Your onboarding handles a life-changing diagnosis like an app registration
A newly diagnosed diabetic is scared, overwhelmed, and deciding whether to trust your program with their health. A consumer-style onboarding – welcome email, feature tour, upsell – completely misreads that moment. The early lifecycle experience has to build confidence and establish the care relationship, and programs that skip that emotional reality lose the member in the first two weeks, before the product ever had a chance to help them.
Adherence campaigns feel like nagging rather than motivation
When members stop logging or scanning, the default lifecycle response is a stream of reminder emails that read as nagging. For a chronic-disease member already carrying guilt about their condition, that tone backfires and drives disengagement. Effective cardiometabolic adherence marketing works with the psychology of behavior change – small wins, honest support, meaning – not reminder fatigue, and most programs have never made that shift.
You lack a re-engagement motion for members who lapse
In diabetes, a lapsed member is not gone – a health scare, a doctor's visit, or a new year can bring them back. But most cardiometabolic companies have no deliberate win-back program, so lapsed members are written off and re-acquired at full cost, if at all. The absence of a re-engagement motion means you are throwing away the members most likely to return with the least marketing spend.
How We Support You
We begin by repositioning lifecycle as the core growth surface it represents in cardiometabolic, then map the complete member journey – onboarding, activation, adherence, re-engagement – against where members actually drop off. Most teams have never viewed lifecycle alongside real attrition, and that map quickly resets where marketing effort belongs: typically away from yet another acquisition push and toward the leaks you have already paid to create.
We redesign onboarding around the chronic-disease moment. The initial experience is built to create trust and establish the care relationship – acknowledging the diagnosis candidly, leading the member toward their first meaningful win, and pacing the journey around emotional reality instead of launching a consumer feature tour. Getting the first two weeks right is the category's highest-leverage lifecycle work because it determines whether an enrolled member becomes an engaged member.
For adherence, we create marketing that works with behavior-change psychology, not against it. Small wins, an honest and supportive tone, and meaning take the place of reminder-fatigue nagging that pushes chronic-disease members away. We build the program to motivate someone managing guilt and fatigue around their condition, a craft fundamentally different from consumer retention marketing.
We create the re-engagement motion most companies lack – an intentional win-back program that reaches lapsed members when they may be receptive to returning, such as after a health scare or at the start of a new year. Since these members cost less to recover than to re-acquire, win-back is often the fastest source of ROI in the entire engagement.
Our difference is that we work as lifecycle marketers who understand cardiometabolic behavior and economics, connected with your growth product, CRM, and experimentation efforts so lifecycle marketing and product retention mechanics reinforce one another. The result is a complete lifecycle program – onboarding, adherence, re-engagement – measured through activation and 90-day adherence, with a testing cadence your team can operate.
What we deliver
- Full member-journey map against real drop-off, reprioritizing lifecycle effort
- Chronic-disease onboarding built to establish trust and drive first meaningful win
- Adherence marketing grounded in behavior-change psychology, not reminder nagging
- Deliberate re-engagement and win-back motion for lapsed members
- Lifecycle program measured on activation and adherence, connected to product and CRM
In cardiometabolic, lifecycle marketing is not simply what follows acquisition – it is the higher-ROI surface. Improving the first two weeks of onboarding outperforms another acquisition push nearly every time.
Our Methodology
We work through a 90-day sprint. During days 1-30, we map the member journey against actual drop-off and identify where lifecycle marketing is breaking down – typically onboarding and the absent win-back motion. In days 31-60, we redesign onboarding for the chronic-disease moment and launch the highest-leverage adherence and re-engagement programs. During days 61-90, we test and optimize against activation and adherence, then hand the program and cadence to your team.
Unlike a generic lifecycle or email agency, we design around the psychology and economics of a chronic-disease relationship rather than a consumer purchase. A standard firm delivers a welcome series and reminder drip; we create onboarding that builds a care relationship and adherence marketing grounded in behavior change, because that is what actually retains a diabetic member. We also link lifecycle marketing with product retention mechanics so they work together rather than compete.
The program is designed for your team to own. By day 90, the journey map, program library, and testing rhythm belong to you. We prefer building your lifecycle engine over running your campaigns forever.
Our Approach
In the first 30 days, we map the member journey against actual drop-off and determine where lifecycle marketing is losing people – a process that almost always challenges the team's belief that acquisition is the issue. By the end of month one, you will have that map and a reprioritized lifecycle plan.
Our side provides a lifecycle marketing operator who understands cardiometabolic behavior, supported by analytics. From your side, we need CRM and marketing owners, a data partner to connect member signals where necessary, and access to clinical input so messaging respects the disease. Lifecycle marketing performs best in coordination with product and CRM teams because the mechanics and messaging must stay aligned.
The operating cadence is a weekly lifecycle review of active programs, performance against activation and adherence, and upcoming launches, with tests scaled to your member volume. Findings flow into your growth product and experimentation efforts so retention stays coordinated.
Engagements generally last three to six months. At completion, you have redesigned onboarding, a psychology-led adherence program, a functioning win-back motion, and a team equipped to run lifecycle. Many clients continue to deepen personalization or extend into additional conditions.
- Enroll-to-activated conversion lift
- 90-day adherence improvement
- Recovered revenue from lapsed members
- Higher return on acquisition spend
If your diabetes & cardiometabolic health company needs lifecycle marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a lifecycle marketing engagement cost for a cardiometabolic company?
The engagement carries a monthly fee over a three-to-six-month build, priced below the cost of a full lifecycle marketing team and well below the cost of continuing to lose members you paid to acquire. You are purchasing a retention program connected to activation and adherence, not a collection of email campaigns. Pricing scales based on how many journeys are included and the level of member-data connection needed. We provide the number during the first call.
How soon will we see results from a lifecycle marketing engagement?
The redesigned onboarding and win-back programs launch in month two, with win-back often delivering quick ROI because lapsed members are inexpensive to recover. Activation lift appears in the second month; measuring the improvement in 90-day adherence requires a complete cohort, with results arriving in month three or four. We prioritize the quickest wins so momentum starts early.
How does the lifecycle team work with our current marketing and product staff?
We embed with and coordinate closely across your CRM and marketing owners, product team, and clinical input for messaging tone. Lifecycle marketing must align with product retention mechanics, so we connect both rather than operating an isolated email program. Results inform your experimentation work, and at the engagement's end, your team owns the journey map, program library, and cadence.
How is Winston Francois different from a conventional lifecycle or email agency?
A conventional agency delivers a welcome series and reminder drip designed for consumer products. We build around the psychology and economics of a chronic-disease relationship – onboarding that creates a care relationship, adherence marketing that supports behavior change rather than nagging, and an intentional win-back motion. We are operators who know cardiometabolic behavior and link lifecycle with your product and CRM, not a firm running generic campaigns.
How is ROI measured for a lifecycle marketing engagement?
We track activation, 90-day adherence, and revenue recovered through win-back – metrics connected to clinical outcomes and payer renewal, alongside the stronger return on acquisition spending. We establish baselines at the outset and evaluate programs by cohort. Because lifecycle closes leaks in a costly acquisition funnel, ROI often appears in acquisition efficiency as much as retention.
How do you create adherence messaging that does not feel like nagging?
We base adherence marketing on behavior-change psychology – small wins, honest and supportive language, and meaning – rather than sending repeated reminders that feel like nagging to a member already dealing with guilt around their condition. The work is about motivating someone managing a chronic disease, which differs fundamentally from consumer retention. We use clinical input to maintain the right tone and align messages with the member's actual trajectory.
Which type of cardiometabolic company is the best fit for this service?
The strongest fit is a Series A through growth-stage diabetes or cardiometabolic company investing meaningful money in acquisition while under-investing in lifecycle, with enough members to identify retention patterns. If you are pre-product-market-fit or serve very few members, lifecycle is too early, and we will tell you. The first step is a call to review your member journey and identify where leaks occur.
